Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week Open-Label Trial of Once-Weekly Fluoxetine for the Treatment of Depression in Patients With End-Stage Renal Disease

NCT00573547 is registered in ClinicalTrials.gov with Creighton University as lead sponsor.

NCT NCT00573547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00573547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week Open-Label Trial of Once-Weekly Fluoxetine for the Treatment of Depression in Patients With End-Stage Renal Disease
Lead sponsor
Creighton University
Phase
Phase 4
Overall status
Withdrawn
Start date
February 28, 2007
Completion date
August 31, 2008
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression